JAZZ

Jazz Pharmaceuticals PLC

Price

$231.19

return (12m)

68.36%

p/e

15.81

p/bv

3.10

DIVIDEND YIELD

0.00%

JAZZ price

Jazz Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment JAZZ

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.54%

3 months

-3.73%

1 year

68.36%

2 years

113.04%

5 years

70.03%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals JAZZ

Valuation

P/E

15.81

Sector -3.34

Industry -3.34

P/BV

3.10

Sector 1.90

Industry 1.90

P/Revenue (PSR)

3.23

Sector 2.02

Industry 2.02

EV/EBITDA

37.47

Sector -219.13

Industry -219.13

EV/EBIT

64.52

Sector -48.17

Industry -48.17

P/EBITDA

9.20

Sector -22.59

Industry -22.59

P/EBIT

16.55

Sector -30.09

Industry -30.09

P/Total Assets

1.34

Sector 1.12

Industry 1.12

P/Net Current Assets

-6.44

Sector -9.63

Industry -9.63

P/Working Capital

8.56

Sector -160.04

Industry -160.04

EPS

14.89

Sector -1.78

Industry -1.78

BVPS

75.98

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

88.42%

Sector 41.35%

Industry 41.35%

EBITDA Margin

35.36%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

20.53%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

19.49%

Sector -35.47%

Industry -35.47%

Net Profit Margins

20.45%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

19.59%

Sector -57.36%

Industry -57.36%

ROA

8.49%

Sector -59.44%

Industry -59.44%

ROIC

14.12%

Sector -2,371.64%

Industry -2,371.64%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.78

Sector 2.91

Industry 2.91

Net Debt / EBITDA

2.66

Sector -22.44

Industry -22.44

Net Debt / EBIT

4.58

Sector -8.34

Industry -8.34

Net Debt / Equity

0.24

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

0.69

Sector -0.85

Industry -0.85

Equity/Assets

0.43

Sector 0.46

Industry 0.46

Liabilities/Assets

0.57

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

8.26%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals JAZZ

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Jazz Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$231.19

Fair Value

$159.55

Upside

-30.99%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
JAZZ Jazz Pharmaceuticals PLC	$231.19	68.04%	0.00%	15.81	3.10	19.59%	20.45%
PFE Pfizer Inc.	$28.11	13.84%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$274.45	23.03%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.26	-32.62%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$142.79	65.52%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$161.17	-4.54%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$59.70	39.95%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$71.55	-49.83%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$414.45	44.80%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$742.12	32.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.79	65.43%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$910.33	23.29%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$505.64	25.50%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$232.16	51.52%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$939.38	19.22%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.34	47.95%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$226.46	47.00%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

JAZZ - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

Average Investor10 user rating

4.0 (2 people)

United States

23 years

Founded: 2003

2007

Time since IPO - 19 years

1.620

Employees

Jazz Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $14.87 billion, with shareholders equity totaling $4.80 billion.

The company employs approximately 1.620 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Jazz Pharmaceuticals PLC reported $4.60 billion in revenue, generating net income of $940.75 million.

Key financial metrics include a P/E ratio of 15.81, a price-to-book (P/B) ratio of 3.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker JAZZ.

Market cap

$14.87 billion

Net worth

$4.80 billion

$4,801,700,000.00

Assets

$11.08 billion

$11,080,900,000.00

Total Shares Outstanding

63.20 million

63,200,000

Average Daily Trading Volume

$902.81 Thousand

$902,809.80

Sector

Health Care

Industry

Biotechnology

JAZZ

JAZZ revenue and profits

Financial Results JAZZ

DRAG THE FRAME TO SEE MORE DATA

JAZZ cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$910.33 20,93% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$232.16 49,05% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$274.45 22,47% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$142.79 70,12% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$161.17 --3,60% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$28.11 17,16% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$59.70 41,84% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$910.33 20,93% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$232.16 49,05% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$274.45 22,47% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$142.79 70,12% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$161.17 --3,60% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$28.11 17,16% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$59.70 41,84% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of Jazz Pharmaceuticals (JAZZ) today?

The current price of Jazz Pharmaceuticals (JAZZ) is $231.19. The stock began the year trading around $170.00 and is currently priced at $231.19. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Jazz Pharmaceuticals (JAZZ) pay dividends?

Jazz Pharmaceuticals (JAZZ) did not pay dividends over the past year.

Is Jazz Pharmaceuticals (JAZZ) a good investment?

Jazz Pharmaceuticals (JAZZ) is currently trading at $231.19 with a P/E ratio of 15.81. This represents a -529% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 68.36%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Jazz Pharmaceuticals (JAZZ) stock?

You can buy Jazz Pharmaceuticals (JAZZ) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol JAZZ and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Jazz Pharmaceuticals (JAZZ) yield today?

Over the past month, Jazz Pharmaceuticals (JAZZ) has returned -4.54% — 68.36% over the past year, and 70.03% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Jazz Pharmaceuticals (JAZZ) today at the current price of $231.19 your total investment would be $23,119.00.

Based on historical performance, the investment would have grown to approximately:

$38,923.15 after 1 year
$39,309.24 after 5 years
$23,119.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

JAZZ

Jazz Pharmaceuticals PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment JAZZ

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING JAZZ WITH OTHER STOCK

ABOUT Jazz Pharmaceuticals

Jazz Pharmaceuticals PLC

United States

23 years

2007

1.620

PROFIT X PRICE JAZZ

Financial Results JAZZ

JAZZ cash flow

Asset, Revenue and Profit Growth - JAZZ

JAZZ balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions